Trial intelligence / Profile preview

Effect of levosimendan on blood coagulation after cardiac surgery

2009-013957-13Phase 4Terminated

Sponsor
Helsinki University Hospital
Start
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in coronary arteriosclerosis comparing Levosimendan (Simdax) with Placebo (2 arms). Primary endpoint: Thromboelastometry parameters. Started Jul 2009; status: terminated.

02

Drugs

levosimendan
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on 2009-013957-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-013957-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call